The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Arutyunova M.S.

Endocrinology Research Centre, Ministry of Health of Russia, Moscow, Russia

Glazunova A.M.

FGBU "Éndokrinologicheskiĭ nauchnyĭ tsentr" Minzdrava RF

Mikhaleva O.V.

Meditsinskiĭ tsentr "Tonus", Nizhniĭ Novgorod

Zuraeva Z.T.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Martynov S.A.

FGBU "Éndokrinologicheskiĭ nauchnyĭ tsentr" Minzdrava RF

Klefortova I.I.

FGBU "ndokrinologicheskiĭ nauchnyĭ tsentr" Minzdrava Rossii, Moskva

Manchenko O.V.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Ul'ianova I.N.

FGBU "Éndokrinologicheskiĭ nauchnyĭ tsentr" Minzdrava RF

Il'in A.V.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Shamkhalova M.Sh.

FGBU "Éndokrinologicheskiĭ nauchnyĭ tsentr" MZ RF, Moskva

Shestakova M.V.

Institut diabeta Éndokrinologicheskogo nauchnogo tsentra, Moskva

Nonglycemic effects of incretins in patients with long-term type 1 diabetes mellitus and chronic kidney disease

Authors:

Arutyunova M.S., Glazunova A.M., Mikhaleva O.V., Zuraeva Z.T., Martynov S.A., Klefortova I.I., Manchenko O.V., Ul'ianova I.N., Il'in A.V., Shamkhalova M.Sh., Shestakova M.V.

More about the authors

Journal: Therapeutic Archive. 2015;87(10): 54‑61

Views: 1774

Downloaded: 470


To cite this article:

Arutyunova MS, Glazunova AM, Mikhaleva OV, et al. . Nonglycemic effects of incretins in patients with long-term type 1 diabetes mellitus and chronic kidney disease. Therapeutic Archive. 2015;87(10):54‑61. (In Russ.)
https://doi.org/10.17116/terarkh2015871054-61

Recommended articles:
Economic analysis of diabetes type 1 screening in children in the Russian Fede­ration. Medi­cal Technologies. Asse­ssment and Choice. 2024;(3):104-114
Diagnosis and treatment of erectile dysfunction in patients with type 1 diabetes mellitus. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(3):5-10

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.